MindImmune Therapeutics, Inc. — Form D/A
MindImmune Therapeutics, Inc. of KINGSTON, RI, a company, filed a Form D amendment with the SEC on 2026-03-05. The offering totals $17.0M, of which $15.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2026-03-05
- Form: D/A
- Accession: 0001792522-26-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $17.0M
- Amount sold: $15.2M
- Remaining: $1.8M
- Investors: 15
- Date of first sale: 2025-11-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-565904
Issuer
- Name: MindImmune Therapeutics, Inc.
- CIK: 0001792522
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 130 FLAGG ROAD, KINGSTON, RI, 02881
- Phone: 401-225-4612
Officers, directors & promoters (19)
| Name | Role | Location |
|---|
| Reetika Bhardwaj | Related Person | Kingston, RI |
| Bradley Margus | Related Person | Kingston, RI |
| Christopher O'Donnell | Related Person | Kingston, RI |
| Isaac Stoner | Related Person | Kingston, RI |
| Isaac Stoner | Director | Kingston, RI |
| Isaac Stoner | Executive Officer | Kingston, RI |
| Reetika Bhardwaj | Director | Kingston, RI |
| Christopher O'Donnell | Director | Kingston, RI |
| Robert Nelson | Executive Officer | Shreveport, LA |
| Bradley Margus | Director | Kingston, RI |
| Robert B Nelson | Director | Kingston, RI |
| Robert B Nelson | Executive Officer | Kingston, RI |
| Tracy Saxton | Director | Kingston, RI |
| Stevin Zorn | Director | Kingston, RI |
| Stevin Zorn | Executive Officer | Kingston, RI |
| Diane Gooding | Executive Officer | Kingston, RI |
| Frank S Menniti | Director | Kingston, RI |
| Frank S Menniti | Executive Officer | Kingston, RI |
| Richard G Horan | Director | Kingston, RI |
Other filings by this issuer (3)
More